Literature DB >> 2187160

Multimodality evoked potentials and early prognosis in comatose patients.

R Firsching1, R A Frowein.   

Abstract

In 112 comatose patients somatosensory, visual and auditory evoked potentials were registered within 36 hours after the onset of coma or admission. Main causes of coma were head injury, and intracerebral and subarachnoid haemorrhage. The initial bilateral loss of any evoked potential was associated with a mortality of 98%. Normal somatosensory evoked potentials were associated with a survival rate of 74%, while normal visual and normal auditory evoked potentials had a survival rate of 60% and 66%, respectively. It is concluded that SEPs can be valuable for the prognosis of coma after primary brain lesions.

Entities:  

Mesh:

Year:  1990        PMID: 2187160     DOI: 10.1007/bf00383655

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  26 in total

1.  Is the auditory brain-stem response (ABR) effective in the assessment of post-traumatic coma?

Authors:  E Facco; A Martini; M Zuccarello; M Agnoletto; G P Giron
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1985-09

2.  The assessment of severe head injury by short-latency somatosensory and brain-stem auditory evoked potentials.

Authors:  B R Cant; A L Hume; J A Judson; N A Shaw
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1986-05

3.  Evaluation of brain function in severe human head trauma with multimodality evoked potentials. Part 1: Evoked brain-injury potentials, methods, and analysis.

Authors:  R P Greenberg; D J Mayer; D P Becker; J D Miller
Journal:  J Neurosurg       Date:  1977-08       Impact factor: 5.115

4.  Prediction of chronic vegetative state with somatosensory evoked potentials.

Authors:  D Zegers de Beyl; E Brunko
Journal:  Neurology       Date:  1986-01       Impact factor: 9.910

5.  Auditory brainstem abnormalities in experimental and clinical acute severe head injury.

Authors:  J W Hall; M Huangfu; T A Gennarelli; C P Kimmelman; C A Dolinskas
Journal:  Trans Pa Acad Ophthalmol Otolaryngol       Date:  1983

6.  Evoked potentials in severe head injury--analysis and relation to outcome.

Authors:  K W Lindsay; J Carlin; I Kennedy; J Fry; A McInnes; G M Teasdale
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-09       Impact factor: 10.154

7.  Assessment of brainstem damage by the auditory brainstem response in acute severe head injury.

Authors:  T Tsubokawa; H Nishimoto; T Yamamoto; M Kitamura; Y Katayama; N Moriyasu
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-11       Impact factor: 10.154

8.  Auditory short, middle, and long latency responses in acutely comatose patients.

Authors:  K Kaga; T Nagai; A Takamori; R R Marsh
Journal:  Laryngoscope       Date:  1985-03       Impact factor: 3.325

9.  Multimodality evoked potentials in closed head trauma.

Authors:  D C Anderson; S Bundlie; G L Rockswold
Journal:  Arch Neurol       Date:  1984-04

10.  Auditory evoked potentials in coma after closed head injury: a clinical-neurophysiologic coma scale for predicting outcome.

Authors:  D S Karnaze; J M Weiner; L F Marshall
Journal:  Neurology       Date:  1985-08       Impact factor: 9.910

View more
  4 in total

Review 1.  Coma After Acute Head Injury.

Authors:  Raimund Firsching
Journal:  Dtsch Arztebl Int       Date:  2017-05-05       Impact factor: 5.594

2.  Prognosis of brain stem lesion in children with head injury.

Authors:  Dieter Woischneck; Susan Klein; Steffen Reissberg; Brigitte Peters; Stefan Avenarius; Gudrun Günther; Raimung Firsching
Journal:  Childs Nerv Syst       Date:  2003-02-21       Impact factor: 1.475

3.  Pyramidal tract lesions in comatose patients.

Authors:  R Firsching; S Wilhelms; R D Hilgers
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

4.  Brain death: practicability of evoked potentials.

Authors:  R Firsching; R A Frowein; S Wilhelms; F Buchholz
Journal:  Neurosurg Rev       Date:  1992       Impact factor: 3.042

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.